Intraoperative and Laparoscopic Ultrasound During Pancreatic Surgery

Chapter

Abstract

Within this chapter we explore the current uses of ultrasound in pancreatic surgery. The first section is dedicated to the discussion of proper preoperative patient setup, intraoperative ultrasound technology, normal anatomic findings, and general indications for use. The second portion of the chapter focuses on disease-specific indications and the ultrasonographic findings associated with these conditions. We conclude by briefly touching on emerging uses of IOUS in pancreatic surgery.

Keywords

Permeability Adenocarcinoma Pancreatitis Syringe Luminal 

Abbreviations

Ao

Aorta

CBD

Common bile duct

Co

Colon

Du

Duodenum

GDA

Gastroduodenal artery

HIFU

High-intensity focused ultrasound

IOUS

Intraoperative ultrasound

IVC

Inferior vena cava

L

Liver

L/RA

L/R renal artery

LUS

Laparoscopic ultrasound

M

Mass

MEN1

Multiple endocrine neoplasia type 1

NET

Neuroendocrine tumor

P

Pancreas

PD

Pancreatic duct

PV

Portal vein

S

Stomach

SA

Splenic artery

SMA

Superior mesenteric artery

SMV

Superior mesenteric vein

SV

Splenic vein

Supplementary material

Video 12.1

Laparoscopic pancreas scanning technique (MOV 101084 kb)

References

  1. 1.
    Sun MRM, Brennan DD, Kruskal JB, Kane RA. Intraoperative ultrasonography of the pancreas. Radiographics. 2010;30(7):1935–53.PubMedCrossRefGoogle Scholar
  2. 2.
    Shin LK, Brant-Zawadzki G, Kamaya A, Jeffrey RB. Intraoperative ultrasound of the pancreas. Ultrasound Q. 2009;25(1):39–48; quiz 48.PubMedCrossRefGoogle Scholar
  3. 3.
    Long EE, Van Dam J, Weinstein S, Jeffrey B, Desser T, Norton JA. Computed tomography, endoscopic, laparoscopic, and intra-operative sonography for assessing resectability of pancreatic cancer. Surg Oncol. 2005;14(2):105–13.PubMedCrossRefGoogle Scholar
  4. 4.
    Jakimowicz JJ. Intraoperative ultrasonography in open and laparoscopic abdominal surgery: an overview. Surg Endosc. 2006;20 Suppl 2:S425–35.PubMedCrossRefGoogle Scholar
  5. 5.
    Lane RJ, Glazer G. Intra-operative B-mode ultrasound scanning of the extra-hepatic biliary system and pancreas. Lancet. 1980;2(8190):334–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Sigel B, Machi J, Ramos JR, Duarte B, Donahue PE. The role of imaging ultrasound during pancreatic surgery. Ann Surg. 1984;200(4):486–93.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Khokhlova TD, Hwang JH. HIFU for palliative treatment of pancreatic cancer. J Gastrointest Oncol. 2011;2(3):175–84.PubMedCentralPubMedGoogle Scholar
  8. 8.
    Jacobs JE, Coleman BG, Arger PH, Langer JE. Pancreatic sparing of focal fatty infiltration. Radiology. 1994;190(2):437–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Bertolotto M, Dalla Palma L, Quaia E, Locatelli M. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results. Eur Radiol. 2000;10(9):1369–76.PubMedCrossRefGoogle Scholar
  10. 10.
    Xu H-X. Contrast-enhanced ultrasound: the evolving applications. World J Radiol. 2009;1(1):15–24.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Piscaglia F, Nolsøe C, Dietrich CF, Cosgrove DO, Gilja OH, Bachmann Nielsen M, et al. The EFSUMB guidelines and recommendations on the clinical practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med. 2012;33(1):33–59.PubMedCrossRefGoogle Scholar
  12. 12.
    Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) – update 2008. Ultraschall Med. 2008;29(1):28–44.PubMedCrossRefGoogle Scholar
  13. 13.
    D’Onofrio M, Martone E, Malagò R. Contrast-enhanced ultrasonography of the pancreas. JOP. 2007;9(5):560–6.Google Scholar
  14. 14.
    Gluck M, Ross A, Irani S, Lin O, Gan SI, Fotoohi M, et al. Dual modality drainage for symptomatic walled-off pancreatic necrosis reduces length of hospitalization, radiological procedures, and number of endoscopies compared to standard percutaneous drainage. J Gastrointest Surg. 2012;16(2):248–56; discussion 256–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Irani S, Gluck M, Ross A, Gan SI, Crane R, Brandabur JJ, et al. Resolving external pancreatic fistulas in patients with disconnected pancreatic duct syndrome: using rendezvous techniques to avoid surgery (with video). Gastrointest Endosc. 2012;76(3):586–93.e3.PubMedCrossRefGoogle Scholar
  16. 16.
    Ripollés T, Martínez MJ, López E, Castelló I, Delgado F. Contrast-enhanced ultrasound in the staging of acute pancreatitis. Eur Radiol. 2010;20(10):2518–23.PubMedCrossRefGoogle Scholar
  17. 17.
    Ros PR, Hamrick-Turner JE, Chiechi MV, Ros LH, Gallego P, Burton SS. Cystic masses of the pancreas. Radiographics. 1992;12(4):673–86.PubMedCrossRefGoogle Scholar
  18. 18.
    D’Onofrio M, Barbi E, Dietrich CF, Kitano M, Numata K, Sofuni A, et al. Pancreatic multicenter ultrasound study (PAMUS). Eur J Radiol. 2012;81(4):630–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Rickes S, Wermke W. Differentiation of cystic pancreatic neoplasms and pseudocysts by conventional and echo-enhanced ultrasound. J Gastroenterol Hepatol. 2004;19(7):761–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang J-Y, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12(3):183–97.PubMedCrossRefGoogle Scholar
  21. 21.
    Kaneko T, Nakao A, Inoue S, Sugimoto H, Hatsuno T, Ito A, et al. Intraoperative ultrasonography by high-resolution annular array transducer for intraductal papillary mucinous tumors of the pancreas. Surgery. 2001;129(1):55–65.PubMedCrossRefGoogle Scholar
  22. 22.
    Cauley CE, Pitt HA, Ziegler KM, Nakeeb A, Schmidt CM, Zyromski NJ, et al. Pancreatic enucleation: improved outcomes compared to resection. J Gastrointest Surg. 2012;16(7):1347–53.PubMedCrossRefGoogle Scholar
  23. 23.
    Turrini O, Schmidt CM, Pitt HA, Guiramand J, Aguilar-Saavedra JR, Aboudi S, et al. Side-branch intraductal papillary mucinous neoplasms of the pancreatic head/uncinate: resection or enucleation? HPB (Oxford). 2011;13(2):126–31.CrossRefGoogle Scholar
  24. 24.
    Brient C, Regenet N, Sulpice L, Brunaud L, Mucci-Hennekine S, Carrère N, et al. Risk factors for postoperative pancreatic fistulization subsequent to enucleation. J Gastrointest Surg. 2012;16(10):1883–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Machi J, Sigel B, Kurohiji T, Zaren HA, Sariego J. Operative ultrasound guidance for various surgical procedures. Ultrasound Med Biol. 1990;16(1):37–42.PubMedCrossRefGoogle Scholar
  26. 26.
    Johnson CD, Stephens DH, Charboneau JW, Carpenter HA, Welch TJ. Cystic pancreatic tumors: CT and sonographic assessment. AJR Am J Roentgenol. 1988;151(6):1133–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Itoh T, Hirooka Y, Itoh A, Hashimoto S, Kawashima H, Hara K, et al. Usefulness of contrast-enhanced transabdominal ultrasonography in the diagnosis of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol. 2005;100(1):144–52.PubMedCrossRefGoogle Scholar
  28. 28.
    D’Onofrio M, Megibow AJ, Faccioli N, Malagò R, Capelli P, Falconi M, et al. Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses. AJR Am J Roentgenol. 2007;189(6):1435–42.PubMedCrossRefGoogle Scholar
  29. 29.
    D’Onofrio M, Gallotti A, Pozzi Mucelli R. Imaging techniques in pancreatic tumors. Expert Rev Med Devices. 2010;7(2):257–73.PubMedCrossRefGoogle Scholar
  30. 30.
    Khurana B, Mortelé KJ, Glickman J, Silverman SG, Ros PR. Macrocystic serous adenoma of the pancreas: radiologic-pathologic correlation. AJR Am J Roentgenol. 2003;181(1):119–23.PubMedCrossRefGoogle Scholar
  31. 31.
    Yeh HC, Stancato-Pasik A, Shapiro RS. Microcystic features at US: a nonspecific sign for microcystic adenomas of the pancreas. Radiographics. 2001;21(6):1455–61.PubMedCrossRefGoogle Scholar
  32. 32.
    Barabino M, Santambrogio R, Pisani Ceretti A, Scalzone R, Montorsi M, Opocher E. Is there still a role for laparoscopy combined with laparoscopic ultrasonography in the staging of pancreatic cancer? Surg Endosc. 2011;25(1):160–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Vargas R, Nino-Murcia M, Trueblood W, Jeffrey RB. MDCT in pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. AJR Am J Roentgenol. 2004;182(2):419–25.PubMedCrossRefGoogle Scholar
  34. 34.
    Prokesch RW, Chow LC, Beaulieu CF, Nino-Murcia M, Mindelzun RE, Bammer R, et al. Local staging of pancreatic carcinoma with multi-detector row CT: use of curved planar reformations initial experience. Radiology. 2002;225(3):759–65.PubMedCrossRefGoogle Scholar
  35. 35.
    Conlon KC, Dougherty E, Klimstra DS, Coit DG, Turnbull AD, Brennan MF. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg. 1996;223(2):134–40.PubMedCentralPubMedCrossRefGoogle Scholar
  36. 36.
    Callery MP, Strasberg SM, Doherty GM, Soper NJ, Norton JA. Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancy. J Am Coll Surg. 1997;185(1):33–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Machi J, Sigel B, Zaren HA, Kurohiji T, Yamashita Y. Operative ultrasonography during hepatobiliary and pancreatic surgery. World J Surg. 1993;17(5):640–5; discussion 645–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Sugiyama M, Hagi H, Atomi Y. Reappraisal of intraoperative ultrasonography for pancreatobiliary carcinomas: assessment of malignant portal venous invasion. Surgery. 1999;125(2):160–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Rumstadt B, Schwab M, Schuster K, Hagmüller E, Trede M. The role of laparoscopy in the preoperative staging of pancreatic carcinoma. J Gastrointest Surg. 1997;1(3):245–50.PubMedCrossRefGoogle Scholar
  40. 40.
    Hann LE, Conlon KC, Dougherty EC, Hilton S, Bach AM, Brennan MF. Laparoscopic sonography of peripancreatic tumors: preliminary experience. AJR Am J Roentgenol. 1997;169:1257–62.PubMedCrossRefGoogle Scholar
  41. 41.
    Kitano M, Kudo M, Maekawa K, Suetomi Y, Sakamoto H, Fukuta N, et al. Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut. 2004;53(6):854–9.PubMedCentralPubMedCrossRefGoogle Scholar
  42. 42.
    D’Onofrio M, Zamboni G, Tognolini A, Malago R, Faccioli N, Frulloni L, et al. Mass-forming pancreatitis: value of contrast-enhanced ultrasonography. World J Gastroenterol. 2006;12(26):4181–4.PubMedCentralPubMedGoogle Scholar
  43. 43.
    Kersting S, Konopke R, Kersting F, Volk A, Distler M, Bergert H, et al. Quantitative perfusion analysis of transabdominal contrast-enhanced ultrasonography of pancreatic masses and carcinomas. Gastroenterology. 2009;137(6):1903–11.PubMedCrossRefGoogle Scholar
  44. 44.
    Numata K, Ozawa Y, Kobayashi N, Kubota T, Shimada H, Nozawa A, et al. Contrast-enhanced sonography of pancreatic carcinoma: correlations with pathological findings. J Gastroenterol. 2005;40(6):631–40.PubMedCrossRefGoogle Scholar
  45. 45.
    Faccioli N, D’Onofrio M, Malagò R, Zamboni G, Falconi M, Capelli P, et al. Resectable pancreatic adenocarcinoma: depiction of tumoral margins at contrast-enhanced ultrasonography. Pancreas. 2008;37(3):265–8.PubMedCrossRefGoogle Scholar
  46. 46.
    Grossjohann HS, Rappeport ED, Jensen C, Svendsen LB, Hillingsø JG, Hansen CP, et al. Usefulness of contrast-enhanced transabdominal ultrasound for tumor classification and tumor staging in the pancreatic head. Scand J Gastroenterol. 2010;45(7–8):917–24.PubMedCrossRefGoogle Scholar
  47. 47.
    Vauthey J-N, Dixon E. AHPBA/SSO/SSAT Consensus conference on resectable and borderline resectable pancreatic cancer: rationale and overview of the conference. Ann Surg Oncol. 2009;16(7):1725–6.PubMedCrossRefGoogle Scholar
  48. 48.
    Margaret T. NCCN guidelines: pancreatic adenocarcinoma. http://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf. Accessed Mar 4 2014.
  49. 49.
    Fendrich V, Bartsch DK, Langer P, Zielke A, Rothmund M. Diagnosis and surgical treatment of insulinoma – experiences in 40 cases. Dtsch Med Wochenschr. 2004;129(17):941–6.PubMedCrossRefGoogle Scholar
  50. 50.
    Norton JA, Cromack DT, Shawker TH, Doppman JL, Comi R, Gorden P, et al. Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation. Ann Surg. 1988;207(2):160–8.PubMedCentralPubMedCrossRefGoogle Scholar
  51. 51.
    Gorman B, Charboneau JW, James EM, Reading CC, Galiber AK, Grant CS, et al. Benign pancreatic insulinoma: preoperative and intraoperative sonographic localization. AJR Am J Roentgenol. 1986;147(5):929–34.PubMedCrossRefGoogle Scholar
  52. 52.
    Grover AC, Skarulis M, Alexander HR, Pingpank JF, Javor ED, Chang R, et al. A prospective evaluation of laparoscopic exploration with intraoperative ultrasound as a technique for localizing sporadic insulinomas. Surgery. 2005;138(6):1003–8; discussion 1008.PubMedCrossRefGoogle Scholar
  53. 53.
    Isla A, Arbuckle JD, Kekis PB, Lim A, Jackson JE, Todd JF, et al. Laparoscopic management of insulinomas. Br J Surg. 2009;96(2):185–90.PubMedCrossRefGoogle Scholar
  54. 54.
    Huai JC, Zhang W, Niu HO, Su ZX, McNamara JJ, Machi J. Localization and surgical treatment of pancreatic insulinomas guided by intraoperative ultrasound. Am J Surg. 1998;175(1):18–21.PubMedCrossRefGoogle Scholar
  55. 55.
    Grant CS, Van Heerden J, Charboneau JW, James EM, Reading CC. Insulinoma. The value of intraoperative ultrasonography. Arch Surg. 1988;123(7):843–8.PubMedCrossRefGoogle Scholar
  56. 56.
    Hiramoto JS, Feldstein VA, LaBerge JM, Norton JA. Intraoperative ultrasound and preoperative localization detects all occult insulinomas. Arch Surg. 2001;136(9):1020–5; discussion 1025–6.PubMedCrossRefGoogle Scholar
  57. 57.
    Akerström G, Hellman P. Surgery on neuroendocrine tumours. Best practice & research. Clin Endocrinol Metab. 2007;21(1):87–109.Google Scholar
  58. 58.
    Machi J, Oishi AJ, Furumoto NL, Oishi RH. Intraoperative ultrasound. Surg Clin North Am. 2004;84(4):1085–111, vi–i.PubMedCrossRefGoogle Scholar
  59. 59.
    Buetow PC, Parrino TV, Buck JL, Pantongrag-Brown L, Ros PR, Dachman AH, et al. Islet cell tumors of the pancreas: pathologic-imaging correlation among size, necrosis and cysts, calcification, malignant behavior, and functional status. AJR Am J Roentgenol. 1995;165(5):1175–9.PubMedCrossRefGoogle Scholar
  60. 60.
    King CM, Reznek RH, Dacie JE, Wass JA. Imaging islet cell tumours. Clin Radiol. 1994;49(5):295–303.PubMedCrossRefGoogle Scholar
  61. 61.
    Buetow PC, Miller DL, Parrino TV, Buck JL. Islet cell tumors of the pancreas: clinical, radiologic, and pathologic correlation in diagnosis and localization. Radiographics. 1997;17(2):453–72; quiz 472A–B.PubMedCrossRefGoogle Scholar
  62. 62.
    Service FJ, McMahon MM, O’Brien PC, Ballard DJ. Functioning insulinoma–incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clinic Proc. 1991;66(7):711–9.CrossRefGoogle Scholar
  63. 63.
    McLean AM, Fairclough PD. Endoscopic ultrasound in the localisation of pancreatic islet cell tumours. Best practice & research. Clin Endocrinol Metablism. 2005;19(2):177–93.Google Scholar
  64. 64.
    Malagò R, D’Onofrio M, Zamboni GA, Faccioli N, Falconi M, Boninsegna L, et al. Contrast-enhanced sonography of nonfunctioning pancreatic neuroendocrine tumors. AJR Am J Roentgenol. 2009;192(2):424–30.PubMedCrossRefGoogle Scholar
  65. 65.
    D’Onofrio M, Vecchiato F, Faccioli N, Falconi M, Pozzi Mucelli R. Ultrasonography of the pancreas. 7. Intraoperative imaging. Abdom Imaging. 2007;32(2):200–6.PubMedCrossRefGoogle Scholar
  66. 66.
    Dietrich CF, Braden B, Hocke M, Ott M, Ignee A. Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound. J Cancer Res Clin Oncol. 2008;134(6):635–43.PubMedCrossRefGoogle Scholar
  67. 67.
    Sofuni A, Moriyasu F, Sano T, Yamada K, Itokawa F, Tsuchiya T, et al. The current potential of high-intensity focused ultrasound for pancreatic carcinoma. J Hepatobiliary Pancreat Sci. 2011;18(3):295–303.PubMedCrossRefGoogle Scholar
  68. 68.
    Wu F, Wang Z-B, Zhu H, Chen W-Z, Zou J-Z, Bai J, et al. Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience. Radiology. 2005;236(3):1034–40.PubMedCrossRefGoogle Scholar
  69. 69.
    Xiong LL, Hwang JH, Huang XB, Yao SS, He CJ, Ge XH, et al. Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer. JOP. 2009;10(2):123–9.PubMedGoogle Scholar
  70. 70.
    Zhao H, Yang G, Wang D, Yu X, Zhang Y, Zhu J, et al. Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer. Anticancer Drugs. 2010;21(4):447–52.PubMedCrossRefGoogle Scholar
  71. 71.
    Alzaraa A, Gravante G, Chung WY, Al-Leswas D, Bruno M, Dennison AR, et al. Targeted microbubbles in the experimental and clinical setting. Am J Surg. 2012;204(3):355–66.PubMedCrossRefGoogle Scholar
  72. 72.
    Goyal K, Einstein D, Ibarra RA, Yao M, Kunos C, Ellis R, et al. Stereotactic body radiation therapy for nonresectable tumors of the pancreas. J Surg Res. 2012;174(2):319–25.PubMedCrossRefGoogle Scholar
  73. 73.
    Kim JH, Hong SS, Kim JH, Park HJ, Chang Y-W, Chang AR, et al. Safety and efficacy of ultrasound-guided fiducial marker implantation for CyberKnife radiation therapy. Korean J Radiol. 2012;13(3):307–13.PubMedCentralPubMedCrossRefGoogle Scholar
  74. 74.
    Rwigema J-CM, Heron DE, Parikh SD, Zeh HJ, Moser JA, Bahary N, et al. Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins. J Gastrointest Cancer. 2012;43(1):70–6.PubMedCrossRefGoogle Scholar
  75. 75.
    Herman JM, Chang DT, Goodman KA, Wild AT, Laheru D, Zheng L, et al. A phase II multi-institutional study to evaluate gemcitabine and fractionated stereotactic body radiotherapy for unresectable, locally advanced pancreatic adenocarcinoma. ASCO Meeting Abstr. 2012;30(15_suppl):4045.Google Scholar
  76. 76.
    Lichtenstein DA. Whole body ultrasonography in the critically ill. Heidelberg: Springer; 2010.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Section of Hepatobiliary SurgeryVirginia Mason Medical CenterSeattleUSA

Personalised recommendations